Maggio N, Firer M, Zaid H, Bederovsky Y, Aboukaoud M, Gandelman-Marton R, Noyman I, Ekstein D, Blatt I, Marom E, et al. Causative drugs of Stevens-Johnson syndrome and toxic epidermal necrolysis in Israel. J Clin Pharmacol.  In Press.

Golenser J, Buchholz V, Bagheri A, Nasereddin A, Dzikowski R, Guo J, Hunt N, Eyal S, Vakruk N, Greiner A. Controlled release of artemisone for the treatment of experimental cerebral malaria. Parasites Vectors.  In Press.

Magdassi S, Bar-David S, Friedman-Levi Y, Zigmond E, Varol C, Lahat G, Klausner J, Eyal S, Nizri E. Intraoperative Localization of Rectal Tumors Using Liposomal Indocyanine Green. Surg Innov.  2017.

Ryu RJ, Eyal S, Easterling TR, Caritis SN, Venkataraman R, Hankins G, Rytting E, Thummel K, Kelly EJ, Risler L, et al. Pharmacokinetics of metoprolol during pregnancy and lactation. J Clin Pharmacol.  2016;56 :581-9.

Roth Y, Neufeld M, Blatt I, Guy-Alfandary S, Rasaby S, Ekstein D, Eyal S. An evaluation of pharmacist knowledge on treatment with antiepileptic drugs. Seizure.  2016;34 :60-5.

Lavi-Blau T, Ekstein D, Neufeld MY, Eyal S. Use of antiepileptic drugs during pregnancy and lactation: Type of information provided by searching Google. Epilepsy Behav.  2016;55 :113-9.

Portnoy E, Vakruk N, Bishara A, Shmuel M, Magdassi S, Golenser J, Eyal S. Indocyanine Green Liposomes for Diagnosis and Therapeutic Monitoring of Cerebral Malaria. Theranostics.  2016;6 :167-76.

Portnoy E, Polyak B, Inbar D, Kenan G, Rai A, Wehrli SL, Roberts TP, Bishara A, Mann A, Shmuel M, et al. Tracking inflammation in the epileptic rat brain by bi-functional fluorescent and magnetic nanoparticles. Nanomedicine.  2016;12 :1335-45.

Meir M, Bishara A, Mann A, Udi S, Portnoy E, Shmuel M, Eyal S. Effects of valproic acid on the placental barrier in the pregnant mouse: Optical imaging and transporter expression studies. Epilepsia.  2016;57 :108-12.

Mann A, Han H, Eyal S. Imaging transporters: Transforming diagnostic and therapeutic development. Clin Pharmacol Ther.  2016;100 :479-88.

Semenenko I, Portnoy E, Aboukaoud M, Guzy S, Shmuel M, Itzhak G, eyal s. Evaluation of near infrared dyes as markers of P-glycoprotein activity in tumors. Frontiers Pharmacol.  2016;7 :426.

Israel S, Maggio N, Ekstein D, Zaid H, Firer M, Bederovsky Y, Noyman I, Gandelman-Marton R, Blatt I, Brautbar C, et al. Genetic risk factors for antiepileptic drug-induced hypersensitivity reactions in Israeli populations. Epilepsia.  2016;57 :e205-9.

Rubinchik-Stern M, Shmuel M, Bar J, Eyal S, Kovo M. Maternal?fetal transfer of indocyanine green across the perfused human placenta. Reprod Toxicol.  2016;62 :100-5.

Berman E, Marom E, Ekstein D, Blatt I, Eyal S. Utilization of antiepileptic drugs in Israel. Epilepsy Behav.  2016;61 :82-5.

Ekstein D, Tirosh M, Eyal Y, Eyal S. Drug interactions involving antiepileptic drugs: assessment of the consistency among three drug compendia and FDA-approved labels. Epilepsy Behav.  2015;44 :218-24.

Portnoy E, Nizri E, Golenser J, Shmuel M, Magdassi S, Eyal S. Imaging the urinary pathways in mice by liposomal indocyanine green. Nanomedicine.  2015;(11) :1057-64.

Mann A, Semenenko I, Meir M, Eyal S. Molecular Imaging of Membrane Transporters' Activity in Cancer: a Picture is Worth a Thousand Tubes. AAPS J.  2015;17 :788-801.

Rubinchik-Stern M, Shmuel M, Eyal S. Antiepileptic drugs alter the expression of placental carriers: An invitro study in a human placental cell line. Epilepsia.  2015;56 :1023-32.

Bishara A, Meir M, Portnoy E, Shmuel M, Eyal S. Near Infrared Imaging of Indocyanine Green Distribution in Pregnant Mice and Effects of Concomitant Medications. Mol Pharm.  2015;12 :3351-7.

Eyal S, Rasaby S, Ekstein D. Concomitant therapy in people with epilepsy: potential drug-drug interactions and patient awareness. Epilepsy Behav.  2014;31 :369-76.

Ryu RJ, Eyal S, Kaplan HG, Akbarzadeh A, Hays K, Puhl K, Easterling TR, Berg SL, Scorsone KA, Feldman EM, et al. Pharmacokinetics of doxorubicin in pregnant women. Cancer Chemother Pharmacol.  2014;73 :789-97.

Deo AK, Borson S, Link JM, Domino K, Eary JF, Ke B, Richards TL, Mankoff DA, Minoshima S, O'Sullivan F, et al. Activity of P-Glycoprotein, a ?-Amyloid Transporter at the Blood-Brain Barrier, Is Compromised in Patients with Mild Alzheimer Disease. J Nucl Med.  2014;55 :1106-11.

Qawasmi I, Shmuel M, Eyal S. Interactions of ABCG2 (BCRP) with epidermal growth factor receptor kinase inhibitors developed for molecular imaging. Front Pharmacol.  2014;5 :257.

Stiebel-Kalish H, Eyal S, Steiner I. The role of aquaporin-1 in idiopathic and drug-induced intracranial hypertension. Med Hypotheses.  2013;81 :1059-62.

Rubinchik-Stern M, Eyal S. Drug Interactions at the Human Placenta: What is the Evidence?. Front Pharmacol.  2012;3 :126.

Portnoy E, Gurina M, Magdassi S, Eyal S. Evaluation of the near infrared compound indocyanine green as a probe substrate of P-glycoprotein. Mol Pharm .  2012;9 :3595-601.

Eyal S, Kim JD, Anderson GD, Buchanan ML, Brateng DA, Carr D, Woodrum DE, Easterling TR, Hebert MF. Atenolol pharmacokinetics and excretion in breast milk during the first 6 months postpartum. J Clinical Pharmacol .  2010;50 :1301-9. .

Claessens AJ, Risler LJ, Eyal S, Shen DD, Easterling TR, Hebert MF. CYP2D6 mediates 4-hydroxylation of clonidine in vitro: implication for pregnancy-induced changes in clonidine clearance. Drug Metab Dispos .  2010;38 :1393-6.

Eyal S, Easterling TR, Carr D, Umans JG, Miodovnik M, Hankins JDV, Clark SM, Risler L, Wang J, Kelly EJ, et al. Pharmacokinetics of metformin during pregnancy. Drug Metab Dispos .  2010;38 :833-40.

Eyal S, Ke B, Muzi M, Link JM, Mankoff DA, Collier A, Unadkat JD. Regional P-glycoprotein activity and inhibition at the human blood-brain barrier as imaged by positron emission tomography. Clin Pharmacol Ther .  2010;87 :579-85. .

Eyal S, Hsiao P, Unadkat JD. Drug interactions at the blood-brain barrier: fact or fantasy?. Pharmacol Ther .  2009;123 :80-104.

Eyal S, Chung F, Muzi M, Link JM, Mankoff DA, Kaddoumi A, O?Sullivan F, Hebert MF, Unadkat JD. Simultaneous PET imaging of P-glycoprotein inhibition in multiple tissues in the pregnant non-human primate. J Nucl Med .  2009;50 :798-806.

Swed A, Eyal S, Madar I, Kontante H, Weiss L, Hoffman A. The role of P-glycoprotein in intestinal transport versus the BBB transport of tetraphenylphosphonium (TPP). Mol Pharm .  2009;6 :1883-90.

Chung F, Eyal S, Muzi M, Link JM, Mankoff DA, Kaddoumi A, Hsiao P, O?Sullivan F, Unadkat JD. Tissue P-glycoprotein activity in the pregnant nonhuman primate changes with gestational age. Br J Pharmacol .  2009;159 :394-404.

Unadkat JD, Chung F, Sasongko L, Whittington D, Eyal S, Mankoff DA, Collier AC, Muzi M, Link J. Rapid solid-phase extraction method to quantify [11C]-verapamil, and its [11C]-metabolites, in human and macaque plasma. Nucl Med Biol.  2008;35 :911-7.

Shimshoni JA, Dalton EC, Jenkins A, Eyal S, Ewan K, Williams RS, Pessah N, B Y, Harwood AJ, Bialer M. The effects of central nervous system-active valproic acid constitutional isomers, cyclopropyl analogs, and amide derivatives on neuronal growth cone behavior. Mol Pharmacol .  2007;71 :884-92.

Eyal S, Lamb JG, Smith-Yockman M, Yagen B, Fibach E, Altschuler Y, White HS, Bialer M. The antiepileptic and anticancer agent, valproic acid, induces P-glycoprotein in human tumour cell lines and in rat liver. Br J Pharmacol .  2006;149 :250-60.

Eyal S, Yagen B, Shimshoni J, Bialer M. Histone deacetylases inhibition and tumor cells cytotoxicity by CNS-active VPA constitutional isomers and derivatives. Biochem Pharmacol.  2005;69 :1501-8.

Hoffman A, Stepensky D, Lavi E, Eyal S, Klausner E, Friedman M. Pharmacokinetic and pharmacodynamic aspects of gastroretentive dosage forms. Int J Pharm .  2004;277 :141-153.

Eyal S, Yagen B, Sobol E, Altschuler Y, Bialer M. The activity of antiepileptic drugs as histone deacetylase inhibitors. Epilepsia.  2004;45 :737-44.

Klausner E, Eyal S, Lavi E, Friedman M, Hoffman A. Novel levodopa gastroretentive dosage form: in vivo evaluation in dogs. J Control Release .  2003;88 :117-6.

Zaidenstein R, Eyal S, Efrati S, Akivison L, Michowitz MK, Nagornov V, Golik A. Adverse drug events in hospitalized patients treated vith cardiovascular drugs and anticoagulants. Pharmacoepidemiol Drug Saf.  2002;11 :235-8.

Eyal S, Weizman A, Toren P, Dor Y, Mester R, Rehavi M. Chronic GnRH administration down-regulates platelet serotonin transporter in women undergoing assisted reproductive treatment. Psychopharmacology .  2001;125 :141-5.